available only through 503A compounding pharmacies under physician supervision Typical research dose range / 200-800 mcg/day subcutaneously, cycled 4-8 weeks Known lethal dose (LD50) / Not established in any species studied to date Rodent acute toxicity ceiling / No mortality observed at doses exceeding 10 mg/kg intraperitoneally Most reported excess-dose symptoms / Nausea, lightheadedness, flushing, injection-site irritation Organ toxicity at supratherapeutic doses / Not demonstrated in published preclinical literature Antidote availability / No specific antidote exists
Adenosylcobalamin injection, a specific type of Vitamin B12 supplementation, offer a bioactive form of B12 crucial for energy metabolism, nerve function, and cellular health when administered directly into the body, supporting overall vitality
S53, compared with the Control, US, and ZFP groups, the proportion of mature DCs and CD8 + T cells in the orthotopic prostate tumors after ZFPG, ZFP + US, and ZFPG + US treatments were significantly up-regulated
Medications to be cautious about include: Acetaminophen (paracetamol) in high doses Certain antibiotics, such as ciprofloxacin Chemotherapy drugs Antipsychotic drugs Always consult your doctor before starting glutathione if you are currently on any medication
There is no consensus on how BPC-157 should be administered or dosed